Abstract: A cryogenic pressure vessel of formed of an ASTM A553 Type 1 cryogenic steel alloy including in wt. %: C: 0.01-0.04; Mn: up to 2.0; P: up to 0.02; S: up to 0.15; Si: up to 1.0; Ni: 7-11; Cr: up to 1.0; Mo: up to 0.75; V: up to 0.2; Nb: up to 0.1; Al: up to 0.1; and N: up to 0.01. The steel alloy may have an ultimate tensile strength of at least 900 MPa, a total elongation of at least 20%; a microstructure including between 5 and 20 area % reverted austenite and the remainder tempered martensite; a transverse Charpy impact energy of at least 27 J at ?196° C.; and a lateral expansion of at least 0.381 mm at ?196° C.

Abstract: The present invention provides methods and systems to predict and diagnose inflammatory bowel disease (IBD) and subtypes such as ulcerative colitis (UC) and Crohn's disease (CD) by detecting the presence, absence, level, and/or genotype of one or more sero-genetic-inflammation markers. Advantageously, with the present invention, it is possible to provide a diagnosis of IBD versus non-IBD, to rule out IBD that is inconclusive for CD and UC, and to differentiate between CD and UC with increased accuracy.

Abstract: The present invention provides methods and systems to predict and diagnose inflammatory bowel disease (IBD) and subtypes such as ulcerative colitis (UC) and Crohn's disease (CD) by detecting the presence, absence, level, and/or genotype of one or more sero-genetic-inflammation markers. Advantageously, with the present invention, it is possible to provide a diagnosis of IBD versus non-IBD, to rule out IBD that is inconclusive for CD and UC, and to differentiate between CD and UC with increased accuracy.

Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.

Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.

Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.

Abstract: The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.

Abstract: A new member of a family of ICE-like cysteine proteases has been identified. The protease family is termed LICE (Like ICE) and the family member described herein is LICE3. LICE3 polypeptides, nucleic acids encoding LICE3 and vectors and host cells for the expression LICE3 are disclosed. Also disclosed are methods for identifying LICE3 agonists and antagonists, and methods for treatment of disorders characterized by altered apoptosis.

Abstract: A new member of a family of ICE-like cysteine proteases has been identified. The protease family is termed LICE (Like ICE) and the family member described herein is LICE3. LICE3 polypeptides, nucleic acids encoding LICE3 and vectors and host cells for the expression LICE3 are disclosed. Also disclosed are methods for identifying LICE3 agonists and antagonists, and methods for treatment of disorders characterized by altered apoptosis.

Abstract: The present specification describes and claims a downhole casing shearer for use in drilling bore holes. The casing shearer comprises an elongate, generally cylindrical sub-member which is connected between a drilling bit and a drill rod string and which engages within a hollow cylindrical shearer, the trailing end of the shearer being connected to a conventional bore hole liner, so that the shearer may rotate about its longitudinal axis with the liner stationary. The sub-member and shearer are interlocked by a releasable locking mechanism which prevents relative rotation therebetween but which allows both for the axial drilling pressure to be applied to the shearer and the shearer to be lifted, and for the drilling bit, sub-member and rod string to be lifted through the liner leaving the shearer and liner in the bore hole, when the locking mechanism is released.